Artificial intelligence (AI) enhances diagnostic accuracy, efficiency, and patient outcomes in radiology. Patient acceptance is essential for successful integration. This study examines patient perspectives on AI in radiology within the UAE, focusing on their knowledge, attitudes, and perceived barriers. Understanding these factors can address concerns, improve trust, and guide patient-centered AI implementation. The findings aim to support effective AI adoption in healthcare. A cross-sectional study involving 205 participants undergoing radiological imaging in the UAE. Data was collected through an online questionnaire, developed based on a literature review, and pre-tested for reliability and validity. Non-probability sampling methods, including convenience and snowball sampling, were employed. The questionnaire assessed participants' knowledge, attitudes, and perceived barriers regarding AI in radiology. Data was analyzed, and categorical variables were expressed as frequencies and percentages. Most participants (89.8 %) believed AI could improve diagnostic accuracy, and 87.8 % acknowledged its role in prioritizing urgent cases. However, only 22 % had direct experience with AI in radiology. While 81 % expressed comfort with AI-based technology, concerns about data security (80.5 %), lack of empathy in AI systems (82.9 %), and insufficient information about AI (85.8 %) were significant barriers. Additionally, (87.3 %) of participants were concerned about the cost of AI implementation. Despite these concerns, 86.3 % believed AI could improve the quality of radiological services, and 83.9 % were satisfied with its potential applications. UAE patients generally support AI in radiology, recognizing its potential for improved diagnostic accuracy. However, concerns about data security, empathy, and understanding of AI technologies necessitate improved patient education, transparent communication, and regulatory frameworks to foster trust and acceptance.

The integration of large language models (LLMs) into medical diagnostics has garnered substantial attention due to their potential to enhance diagnostic accuracy, streamline clinical workflows, and address health care disparities. However, the rapid evolution of LLM research necessitates a comprehensive synthesis of their applications, challenges, and future directions. This scoping review aimed to provide an overview of the current state of research regarding the use of LLMs in medical diagnostics. The study sought to answer four primary subquestions, as follows: (1) Which LLMs are commonly used? (2) How are LLMs assessed in diagnosis? (3) What is the current performance of LLMs in diagnosing diseases? (4) Which medical domains are investigating the application of LLMs? This scoping review was conducted according to the Joanna Briggs Institute Manual for Evidence Synthesis and adheres to the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Relevant literature was searched from the Web of Science, PubMed, Embase, IEEE Xplore, and ACM Digital Library databases from 2022 to 2025. Articles were screened and selected based on predefined inclusion and exclusion criteria. Bibliometric analysis was performed using VOSviewer to identify major research clusters and trends. Data extraction included details on LLM types, application domains, and performance metrics. The field is rapidly expanding, with a surge in publications after 2023. GPT-4 and its variants dominated research (70/95, 74% of studies), followed by GPT-3.5 (34/95, 36%). Key applications included disease classification (text or image-based), medical question answering, and diagnostic content generation. LLMs demonstrated high accuracy in specialties like radiology, psychiatry, and neurology but exhibited biases in race, gender, and cost predictions. Ethical concerns, including privacy risks and model hallucination, alongside regulatory fragmentation, were critical barriers to clinical adoption. LLMs hold transformative potential for medical diagnostics but require rigorous validation, bias mitigation, and multimodal integration to address real-world complexities. Future research should prioritize explainable artificial intelligence frameworks, specialty-specific optimization, and international regulatory harmonization to ensure equitable and safe clinical deployment.

Software programs leveraging artificial intelligence to detect vessel occlusions are now widely available to aid in stroke triage. Given their proprietary use, there is a surprising lack of information regarding how the software works, who is using the software, and their performance in an unbiased real-world setting. In this educational review of automated vessel occlusion software, we discuss emerging evidence of their utility, underlying algorithms, real-world diagnostic performance, and limitations. The intended audience includes specialists in stroke care in neurology, emergency medicine, radiology, and neurosurgery. Practical tips for onboarding and utilization of this technology are provided based on the multidisciplinary experience of the authorship team.

The exponential rise in the artificial intelligence (AI) tools for medical imaging is profoundly impacting the practice of radiology. With over 1000 FDA-cleared AI algorithms now approved for clinical use-many of them designed for radiologic tasks-the responsibility lies with training institutions to ensure that radiology residents are equipped not only to use AI systems, but to critically evaluate, monitor, respond to their output in a safe, ethical manner. This review proposes a comprehensive framework to integrate AI into radiology residency curricula, targeting both essential competencies required of all residents, optional advanced skills for those interested in research or AI development. Core educational strategies include structured didactic instruction, hands-on lab exposure to commercial AI tools, case-based discussions, simulation-based clinical pathways, teaching residents how to interpret model cards, regulatory documentation. Clinical examples such as stroke triage, Urinary tract calculi detection, AI-CAD in mammography, false-positive detection are used to anchor theory in practice. The article also addresses critical domains of AI governance: model transparency, ethical dilemmas, algorithmic bias, the role of residents in human-in-the-loop oversight systems. It outlines mentorship, faculty development strategies to build institutional readiness, proposes a roadmap to future-proof radiology education. This includes exposure to foundation models, vision-language systems, multi-agent workflows, global best practices in post-deployment AI monitoring. This pragmatic framework aims to serve as a guide for residency programs adapting to the next era of radiology practice.

Artificial intelligence (AI) is rapidly transforming healthcare, but its benefits are not reaching all patients equally. Children remain overlooked with only 17% of FDA-approved medical AI devices labeled for pediatric use. In this work, we demonstrate that this exclusion may stem from a fundamental data gap. Our systematic review of 181 public medical imaging datasets reveals that children represent just under 1% of available data, while the majority of machine learning imaging conference papers we surveyed utilized publicly available data for methods development. Much like systematic biases of other kinds in model development, past studies have demonstrated the manner in which pediatric representation in data used for models intended for the pediatric population is essential for model performance in that population. We add to these findings, showing that adult-trained chest radiograph models exhibit significant age bias when applied to pediatric populations, with higher false positive rates in younger children. This work underscores the urgent need for increased pediatric representation in publicly accessible medical datasets. We provide actionable recommendations for researchers, policymakers, and data curators to address this age equity gap and ensure AI benefits patients of all ages. 1-2 sentence summaryOur analysis reveals a critical healthcare age disparity: children represent less than 1% of public medical imaging datasets. This gap in representation leads to biased predictions across medical image foundation models, with the youngest patients facing the highest risk of misdiagnosis.

Artificial intelligence (AI) tools for large vessel occlusion (LVO) detection are increasingly used in acute stroke triage to expedite diagnosis and intervention. However, variability in access and workflow integration limits their potential impact. This study assessed current usage patterns, access disparities, and integration levels across U.S. stroke programs. Cross-sectional, web-based survey of 97 multidisciplinary stroke care providers from diverse institutions. Descriptive statistics summarized demographics, AI tool usage, access, and integration. Two-proportion Z-tests assessed differences across institutional types. Most respondents (97.9%) reported AI tool use, primarily Viz AI and Rapid AI, but only 62.1% consistently used them for triage prior to radiologist interpretation. Just 37.5% reported formal protocol integration, and 43.6% had designated personnel for AI alert response. Access varied significantly across departments, and in only 61.7% of programs did all relevant team members have access. Formal implementation of the AI detection tools did not differ based on the certification (z = -0.2; <i>p</i> = 0.4) or whether the program was academic or community-based (z =-0.3; <i>p</i> = 0.3). AI-enabled LVO detection tools have the potential to improve stroke care and patient outcomes by expediting workflows and reducing treatment delays. This survey effectively evaluated current utilization of these tools and revealed widespread adoption alongside significant variability in access, integration, and workflow standardization. Larger, more diverse samples are needed to validate these findings across different hospital types, and further prospective research is essential to determine how formal integration of AI tools can enhance stroke care delivery, reduce disparities, and improve clinical outcomes.

Generative AI tools have proliferated across the market, garnered significant media attention, and increasingly found incorporation into the radiology practice setting. However, they raise a number of unanswered questions concerning governance and appropriate use. By their nature as general-purpose technologies, they strain the limits of existing FDA premarket review pathways to regulate them and introduce new sources of liability, privacy, and clinical risk. A multilayered governance approach is needed to balance innovation with safety. To address gaps in oversight, this piece establishes a trilaminar governance model for generative AI technologies. This treats federal regulations as a scaffold, upon which tiers of institutional guidelines and industry self-regulatory frameworks are added to create a comprehensive paradigm composed of interlocking parts. Doing so would provide radiologists with an effective risk management strategy for the future, foster continued technical development, and ultimately, promote patient care.

Recent advances in Artificial Intelligence (AI) methodologies and their application to medical imaging has led to an explosion of related research programs utilizing AI to produce state-of-the-art classification performance. Ideally, research culminates in dissemination of the findings in peer-reviewed journals. To date, acceptance or rejection criteria are often subjective; however, reproducible science requires reproducible review. The Machine Learning Education Sub-Committee of the Society for Imaging Informatics in Medicine (SIIM) has identified a knowledge gap and need to establish guidelines for reviewing these studies. This present work, written from the machine learning practitioner standpoint, follows a similar approach to our previous paper related to segmentation. In this series, the committee will address best practices to follow in AI-based studies and present the required sections with examples and discussion of requirements to make the studies cohesive, reproducible, accurate, and self-contained. This entry in the series focuses on image classification. Elements like dataset curation, data pre-processing steps, reference standard identification, data partitioning, model architecture, and training are discussed. Sections are presented as in a typical manuscript. The content describes the information necessary to ensure the study is of sufficient quality for publication consideration and, compared with other checklists, provides a focused approach with application to image classification tasks. The goal of this series is to provide resources to not only help improve the review process for AI-based medical imaging papers, but to facilitate a standard for the information that should be presented within all components of the research study.

As many radiology departments embark on adopting artificial intelligence (AI) solutions in their clinical practice, they face the challenge that commercial applications often do not fit with their needs. As a result, they engage in a co-creation process with technology companies to collaboratively develop and implement AI solutions. Despite its importance, the process of co-creating AI solutions is under-researched, particularly regarding the range of challenges that may occur and how medical and technological parties can monitor, assess, and guide their co-creation process through an effective collaboration framework. Drawing on the multi-case study of three co-creation projects at an academic medical center in the Netherlands, we examine how co-creation processes happen through different scenarios, depending on the extent to which the two parties engage in "resourcing," "adaptation," and "reconfiguration." We offer a relational framework that helps involved parties monitor, assess, and guide their collaborations in co-creating AI solutions. The framework allows them to discover novel use-cases and reconsider their established assumptions and practices for developing AI solutions, also for redesigning their technological systems, clinical workflow, and their legal and organizational arrangements. Using the proposed framework, we identified distinct co-creation journeys with varying outcomes, which could be mapped onto the framework to diagnose, monitor, and guide collaborations toward desired results. The outcomes of co-creation can vary widely. The proposed framework enables medical institutions and technology companies to assess challenges and make adjustments. It can assist in steering their collaboration toward desired goals. Question How can medical institutions and AI startups effectively co-create AI solutions for radiology, ensuring alignment with clinical needs while steering collaboration effectively? Findings This study provides a co-creation framework allowing assessment of project progress, stakeholder engagement, as well as guidelines for radiology departments to steer co-creation of AI. Clinical relevance By actively involving radiology professionals in AI co-creation, this study demonstrates how co-creation helps bridge the gap between clinical needs and AI development, leading to clinically relevant, user-friendly solutions that enhance the radiology workflow.

Cancer continues to be a significant international health issue, which demands the invention of new methods for early detection, precise diagnoses, and personalized treatments. Artificial intelligence (AI) has rapidly become a groundbreaking component in the modern era of oncology, offering sophisticated tools across the range of cancer care. In this review, we performed a systematic survey of the current status of AI technologies used for cancer diagnoses and therapeutic approaches. We discuss AI-facilitated imaging diagnostics using a range of modalities such as computed tomography, magnetic resonance imaging, positron emission tomography, ultrasound, and digital pathology, highlighting the growing role of deep learning in detecting early-stage cancers. We also explore applications of AI in genomics and biomarker discovery, liquid biopsies, and non-invasive diagnoses. In therapeutic interventions, AI-based clinical decision support systems, individualized treatment planning, and AI-facilitated drug discovery are transforming precision cancer therapies. The review also evaluates the effects of AI on radiation therapy, robotic surgery, and patient management, including survival predictions, remote monitoring, and AI-facilitated clinical trials. Finally, we discuss important challenges such as data privacy, interpretability, and regulatory issues, and recommend future directions that involve the use of federated learning, synthetic biology, and quantum-boosted AI. This review highlights the groundbreaking potential of AI to revolutionize cancer care by making diagnostics, treatments, and patient management more precise, efficient, and personalized.